NIH-funded research NIH-funded research

How certain gut protists help protect our gut health

Official title: Protective impacts of commensal protists on the human gut microbiome

Funded at Georgia Institute of Technology · NIH-11061048 · Data updated 2026-11-12

This study is looking at a tiny organism called Blastocystis that lives in our gut to see if it can help protect us from gut inflammation, and it's for anyone interested in how our gut health can be improved by understanding the good roles these organisms might play.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionGeorgia Institute of Technology
NIH-funded
Lab location1 site (Atlanta, United States)
Project startMarch 22, 2024
Project endFebruary 28, 2026
Funding year2025
Award (this year)$107,129
NIH project number5K22AI173181-02
Project IDNIH-11061048 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with gut health issues or those interested in understanding the role of their gut microbiome.

Less likely to help

Patients who do not have any gut health concerns or those who are not interested in microbiome research may not benefit from this research.

What this research studies

This research investigates the role of commensal protists, specifically Blastocystis, in the human gut microbiome and their potential protective effects against gut inflammation. The study aims to understand how these protists interact with gut bacteria and the human host by analyzing their genomes and exploring mechanisms such as bacterial predation and metabolite production. By generating high-quality genomic data, the research seeks to challenge the traditional view that these protists are harmful and instead highlight their beneficial roles in gut health.

Why it matters

Potential benefit: If successful, this research could lead to new insights into gut health and the development of therapies that harness the protective effects of commensal protists.

How similar studies have gone: While the role of bacteria in the microbiome has been extensively studied, the investigation of commensal protists is relatively novel, suggesting this research could pave the way for new discoveries.

Where this research is happening

  • Georgia Institute of Technology
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Lind, Abigail — Georgia Institute of Technology
  • Study coordinator: Lind, Abigail

Related research

Other NIH-funded projects on the same topics.

  • Multi-agent AI to annotate enzymes in the human gut microbiome

    A team at a major university will build an AI system that automatically curates and labels the functions of enzymes in the human gut microbiome to speed up understanding their health effects.

    NIH research University of South Florida · Tampa, United States · NIH-11594384

  • Mapping how gut bacteria transform drugs

    Scientists will study how the gut microbiome changes thousands of drugs into new forms, which could affect how well a medicine works or whether it causes side effects.

    NIH research Stanford University · Stanford, United States · NIH-11550022

  • Aflatoxin exposure and child growth in Guatemala

    A study in rural Guatemala will track how exposure to aflatoxin relates to growth and gut health in young children.

    NIH research Arizona State University-Tempe Campus · Scottsdale, United States · NIH-11513260

  • Gut bacteria that can make cancer immunotherapy less effective

    This project will see if reducing chronic inflammation driven by certain gut bacteria can help immunotherapy work better for people whose cancers have stopped responding.

    NIH research University of Tx Md Anderson Can Ctr · Houston, United States · NIH-11478145

  • How gut bacteria affect how cancer drugs work

    This project looks at how the bacteria in your gut might change how well and with what side effects fluoropyrimidine cancer drugs like 5-FU work in people.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473234

  • Gut bacteria and cancer drugs: how your gut may change chemotherapy effectiveness

    This project studies how the gut microbiome might affect how well certain chemotherapy drugs work and their side effects in people with cancer.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473233

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.